NovaBridge Biosciences (NBP) Other Non Operating Income (2019 - 2025)

NovaBridge Biosciences (NBP) has reported Other Non Operating Income for 5 consecutive years, with -$1.8 million the latest figure, recorded in Q4 2025.

• Quarterly Other Non Operating Income fell 630.3% year-over-year to -$1.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$1.7 million (up 64.35% YoY) and the FY2025 annual result came in at -$1.7 million, up 64.35% from the prior year.
• Other Non Operating Income slipped to -$1.8 million in Q4 2025 per NBP's latest filing, from $14000.0 in the prior quarter.
• Over the last five years, Other Non Operating Income for NBP reached as high as $6.1 million in Q2 2024 and fell as low as -$16.4 million in Q2 2023.
• A 3-year average of -$1.8 million and a median of $14000.0 in 2025 frame the typical range for Other Non Operating Income.
• The largest YoY upside for Other Non Operating Income was 141.57% in 2025 against a maximum downside of 630.3% in 2025.
• Year by year, Other Non Operating Income stood at $1.0 million in 2023, then plunged by 67.39% to $330000.0 in 2024, then plunged by 630.3% to -$1.8 million in 2025.
• According to Business Quant data, Other Non Operating Income over the past three periods registered -$1.8 million, $14000.0, and -$190000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.